- Used for moderate to severe plaque psoriasis
- Anti-IL-17A monoclonal antibody
Adverse Events
- Common: neutropenia, hypersensitivity reactions, infections including pneumonia, injection site reactions
- Uncommon: superficial fungal infections, nausea, thrombocytopenia, antibody development
- Rare: Crohn disease and ulcerative colitis (including causing exacerbations), oral candidiasis, influenza, conjunctivitis, and rhinitis
